Table 2.
Pleural effusion variables between loculated and nonloculated tuberculous pleural effusion.
| All patients | Loculated TBPE | Nonloculated TBPE | P value† | |
|---|---|---|---|---|
| (n = 42) | (n = 26) | (n = 16) | ||
| Effusion CXR score, %, mean ± SD | 53 ± 20 | 56 ± 21 | 43 ± 12 | 0.025 |
|
| ||||
| ADA, IU/L | 99 | 108 | 86 | 0.100 |
| (66–185) | (82–203) | (59–149) | ||
|
| ||||
| pH value | 7.30 | 7.27 | 7.36 | <0.001 |
| (7.22–7.35) | (7.22–7.30) | (7.33–7.41) | ||
|
| ||||
| Glucose, mg/dL | 116 | 98 | 120 | 0.038 |
| (75–138) | (75–118) | (99–142) | ||
|
| ||||
| Protein, g/L | 5.0 | 4.8 | 5.2 | 0.089 |
| (4.1–5.3) | (4.1–5.2) | (4.2–5.6) | ||
|
| ||||
| LDH, IU/dL | 307 | 387 | 210 | 0.002 |
| (229–533) | (287–723) | (154–388) | ||
|
| ||||
| Leukocyte count, cells/μL | 1598 | 1665 | 1437 | 0.449 |
| (963–3880) | (1330–3880) | (720–2000) | ||
|
| ||||
| PAI-1, ng/mL | 114.6 | 138.5 | 105.5 | <0.001 |
| (105.5–199.0) | (114.8–213.0) | (96.0–113.0) | ||
|
| ||||
| tPA, ng/mL | 17.0 | 15.9 | 24.9 | <0.01 |
| (10.0–23.0) | (8.4–20.5) | (14.4–28.7) | ||
|
| ||||
| PAI-1/tPA ratio | 7.6 | 13.4 | 4.6 | 0.036 |
| (5.0–14.0) | (7.6–18.4) | (1.8–6.8) | ||
|
| ||||
| IL-8, pg/mL | 365 | 419 | 167 | <0.001 |
| (220–637) | (312–1442) | (79–395) | ||
|
| ||||
| VEGF, pg/mL | 693 | 969 | 510 | <0.001 |
| (499–1909) | (571–2054) | (161–713) | ||
TBPE: tuberculous pleural effusion; effusion CXR score: portion of hemithorax opacified by pleural effusion on posteroanterior chest radiograph; ADA: adenosine deaminase; LDH: lactate dehydrogenase; PAI-1: plasminogen activator inhibitor-1; tPA: tissue type plasminogen activator; IL-8: interleukin-8; VEGF: vascular endothelial growth factor.
Data are presented as median (IQR) unless specified.
†For comparisons between loculated and nonloculated TBP groups.